Molecular Partners Ag (MOLN) Equity Average: 2021-2025
Historic Equity Average for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $145,139.
- Molecular Partners Ag's Equity Average fell 64.81% to $145,139 in Q3 2025 from the same period last year, while for Sep 2025 it was $145,139, marking a year-over-year decrease of 64.81%. This contributed to the annual value of $200,526 for FY2024, which is 18.66% down from last year.
- Per Molecular Partners Ag's latest filing, its Equity Average stood at $145,139 for Q3 2025, which was down 5.45% from $153,509 recorded in Q2 2025.
- In the past 5 years, Molecular Partners Ag's Equity Average ranged from a high of $14.7 million in Q4 2021 and a low of $145,139 during Q3 2025.
- Its 3-year average for Equity Average is $247,546, with a median of $235,278 in 2023.
- In the last 5 years, Molecular Partners Ag's Equity Average plummeted by 98.09% in 2022 and then soared by 65.06% in 2024.
- Over the past 5 years, Molecular Partners Ag's Equity Average (Quarterly) stood at $14.7 million in 2021, then tumbled by 98.09% to $281,681 in 2022, then decreased by 16.47% to $235,278 in 2023, then decreased by 23.72% to $179,477 in 2024, then crashed by 64.81% to $145,139 in 2025.
- Its Equity Average stands at $145,139 for Q3 2025, versus $153,509 for Q2 2025 and $168,949 for Q1 2025.